STEVIOL GLYCOSIDE TRANSPORT
    18.
    发明申请

    公开(公告)号:US20240400623A1

    公开(公告)日:2024-12-05

    申请号:US18809132

    申请日:2024-08-19

    Abstract: The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polytpeptide when measured under the same conditions.

    NOVEL USE OF AT LEAST A HUMAN MILK OLIGOSACCHARIDE

    公开(公告)号:US20240374624A1

    公开(公告)日:2024-11-14

    申请号:US18685028

    申请日:2022-08-23

    Abstract: The present invention relates to compositions comprising at least one human milkoligosaccharide selected from the group consisting of 2′-fucosyllactose, difucosyllactose and/or lacto-N-tetraose as an anti-microbial agent against Cutibacterium acnes (C. acnes) as well as the use thereof in a regimen to prevent and/or treat acne comprising the steps of topically administering a composition comprising said human milk oligosaccharide(s) to the skin of a subject with acne/acne prone skin followed by topically administering a composition comprising one or more non-pathogenic live bacterial C. acnes strains.

Patent Agency Ranking